Close

Ultragenyx Pharma (RARE) PT Raised to $61 at TD Cowen Apr 24, 2024 09:42AM
Ultragenyx to Participate at Investor Conferences in March Feb 27, 2024 04:30PM
Ultragenyx Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 23, 2023 04:01PM
Ultragenyx Pharma (RARE) Prices 8.33M Share and Warrant Offering at $30/sh Oct 19, 2023 05:49AM
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Oct 18, 2023 09:16PM
View Older Stories

Oct 17, 2023 04:03PM Ultragenyx Pharma (RARE) Announces Proposed $300M Share Offering
Oct 17, 2023 04:02PM Ultragenyx Announces Proposed Public Offering of Common Stock
Feb 28, 2023 04:01PM Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
Feb 28, 2023 04:01PM Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
Jul 14, 2022 08:34AM Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS
Jul 14, 2022 08:30AM Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets
Jul 14, 2022 08:30AM Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets
Mar 2, 2022 04:01PM Ultragenyx to Participate in the Cowen Health Care Conference
Mar 2, 2022 04:01PM Ultragenyx to Participate in the Cowen Health Care Conference
Jan 10, 2022 01:42PM Ultragenyx Pharma (RARE) PT Lowered to $124 at Cowen, Following Earnings
Feb 17, 2021 04:01PM Ultragenyx to Present at Upcoming Investor Conferences
Feb 17, 2021 04:01PM Ultragenyx to Present at Upcoming Investor Conferences
Nov 2, 2020 11:20AM Ultragenyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 2, 2020 11:20AM Ultragenyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 29, 2020 05:54AM Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/Sh
Oct 28, 2020 07:00PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Oct 28, 2020 07:00PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Pharma (RARE) Announces Proposed $400M Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Announces Proposed Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Announces Proposed Public Offering of Common Stock
Oct 28, 2020 06:59AM Ultragenyx Pharma (RARE) PT Raised to $116 at Cowen
Jan 24, 2020 06:37AM Ultragenyx Pharma (RARE) PT Raised to $75 at Cowen
May 7, 2019 07:53AM Ultragenyx Pharma (RARE) PT Raised to $79 at Cowen on Strong Crysvita Sales
Mar 11, 2019 08:30AM Ultragenyx to Present at Upcoming Investor Conferences
Mar 11, 2019 04:30AM Ultragenyx to Present at Upcoming Investor Conferences
Feb 27, 2019 05:49AM Ultragenyx Pharma (RARE) Prices 5.07M Share Common Offering at $60/Sh
Feb 26, 2019 07:13PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Feb 26, 2019 07:13PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Feb 25, 2019 04:07PM Cowen Starts Ultragenyx Pharma (RARE) at Outperform
Feb 25, 2019 04:02PM Ultragenyx Pharma (RARE) to Offer Up to $250M in CommonStock
Feb 25, 2019 04:01PM Ultragenyx Announces Proposed Public Offering of Common Stock
Feb 25, 2019 04:01PM Ultragenyx Announces Proposed Public Offering of Common Stock
Mar 8, 2018 08:00AM Ultragenyx to Present at Upcoming Investor Conferences
Mar 8, 2018 08:00AM Ultragenyx to Present at Upcoming Investor Conferences
Jan 24, 2018 05:49AM Ultragenyx Pharma (RARE) Prices 4.386M Share Common Offering at $57/Sh
Jan 23, 2018 09:40PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Jan 23, 2018 09:40PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Jan 22, 2018 04:16PM Ultragenyx Pharma (RARE) Plans $175M Public Offering of Common Stock
Jan 22, 2018 04:15PM Ultragenyx Announces Proposed Public Offering of Common Stock
Jan 22, 2018 04:15PM Ultragenyx Announces Proposed Public Offering of Common Stock
Jun 29, 2017 06:23AM Ultragenyx Pharma (RARE): NDR Focuses On Burosumab, Reit Outperform - Cowen
Apr 19, 2017 07:08AM Cowen Reiterates Outperform Rating on Ultragenyx Pharma (RARE); 'Phase III Burosumab Data Supportive Of A Broad XLH Label'
Mar 2, 2017 08:30AM Ultragenyx to Present at Upcoming Investor Conferences
Jul 5, 2016 06:26AM Ultragenyx Pharma (RARE) Discloses $150M At-The-Market Offering Through Cowen
Jun 17, 2016 09:31AM Pre-Open Stock Movers 06/17: (RDEN) (PRTK) (FNSR) (SHWC) (LL) Higher; (GLYC) (CMTL) Lower (more...)
Mar 2, 2016 04:05PM Ultragenyx to Present at the Cowen and Company 36th Annual Health Care Conference
Jul 27, 2015 09:35AM Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)
Jul 21, 2015 04:30PM Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares
Jul 21, 2015 04:30PM Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares
Jul 16, 2015 06:43AM Ultragenyx Pharma (RARE) Prics 2.2M Common Stock Offering at $120/Share
View Older Stories